Sword Diagnostics, Inc. products
Ligand Binding Assays & ELISAs
Sword Method Development Scientists are experts in the rapid development and performance qualification of Ligand Binding Assays (LBAs) that are specific for a client’s unique needs.
Sword Nuc-Cyte - DNA-Binding Assays
In response to our client’s needs, Sword Method Development Scientists have developed our proprietary Nuc-Cyte™ DNA-Binding Platform for the identification and quantitation of cellular transcription factors.
Immunogenicity Assays - Anti-Drug Antibody Assays
Whenever large molecular biologics (proteins) are administered to a patient, the patient can potentially develop antibodies to the therapeutic, known as anti-drug antibodies (ADAs). The detection, quantitation, and determination of the isotype of drug-induced ADAs are critical to the understanding of the etiology of these antibodies and the effect that ADAs may have on the efficacy of the patient’s treatment.